The Next Clinical Frontier: 42% of Frontline Leaders Demand Menopause Innovation

42% of clinicians identify Menopause as the area requiring the greatest clinical innovation over the next five years.

Boston MA -- October 14: Frontline healthcare providers are urgently signaling that the industry's focus must broaden beyond traditional reproductive timelines.

The Women's Health Infrastructure Report 2026 confirms that clinicians are decisively adopting a lifespan perspective, driving a massive demand for innovation in midlife care and chronic condition management.

Among all conditions evaluated, clinicians most frequently selected menopause (42%) as the primary target for future innovation. Interestingly, autoimmune conditions (26%) placed second, while traditional maternal health (16%) and cardiovascular disease (11%) fell further down the priority list, reflecting an acute awareness of historical under-investment in midlife female health.

"Women's health is still too often approached as a series of isolated events rather than across the entire lifespan. Pregnancy can serve as an early window into a woman's future health-with hypertensive disorders directly signaling elevated cardiovascular risk later in life. We must invest in longitudinal clinical research..."

Lindsey Miltenberger

Chief Advocacy Officer, Society for Women's Health Research

This finding represents just one of dozens of insights uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.

The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.

Lead Research Partner